论文部分内容阅读
目的:探讨高风险初产妇妊娠期糖尿病的筛查对新生儿的影响。方法:将来该院进行产前检查的高风险初产妇65例作为调查对象,通过回顾分析法,对所有患者进行妊娠期糖尿病筛查,并依照患者的血糖水平将其分为治疗组33例与对照组32例,对比两组患者的不良反应、并发症发生率、剖宫产率等;同时采用Apgar对新生儿情况进行评分,比较围产儿的并发症发生率。结果:经比较,治疗组的不良反应、并发症发生率、剖宫产率都比对照组低(P<0.05)。治疗组的Apgar评分与围产儿并发症发生率要优于对照组(P<0.05)。结论:对高风险初产妇进行妊娠期糖尿病筛查与干预,可以有效减少围产儿的并发症发生率,值得临床推广。
Objective: To investigate the impact of high-risk primiparous screening of gestational diabetes on newborns. Methods: In the future, 65 high-risk primipara in prenatal examination in our hospital were investigated. Through retrospective analysis, all patients were screened for gestational diabetes mellitus. According to their blood glucose level, they were divided into treatment group (33 cases) and Control group of 32 patients, the two groups of patients adverse reactions, complication rates, cesarean section rate; at the same time the use of Apgar neonates score, comparison of perinatal complications. Results: Compared with the control group, adverse reaction, complication rate and cesarean section rate in the treatment group were lower than those in the control group (P <0.05). Apgar score and perinatal complications in the treatment group were better than those in the control group (P <0.05). Conclusion: Screening and intervention of gestational diabetes in high-risk primipara can effectively reduce the incidence of perinatal complications and is worthy of clinical promotion.